Ocugen Files 8-K: Other Events & Financials
Ticker: OCGN · Form: 8-K · Filed: Jan 29, 2025 · CIK: 1372299
| Field | Detail |
|---|---|
| Company | Ocugen, INC. (OCGN) |
| Form Type | 8-K |
| Filed Date | Jan 29, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, corporate-update
Related Tickers: OCGN
TL;DR
OCGN filed an 8-K on Jan 29, 2025, covering general corporate updates.
AI Summary
Ocugen, Inc. filed an 8-K on January 29, 2025, reporting other events and financial statements. The company, previously known as Histogenics Corp, is incorporated in Delaware and headquartered in Malvern, PA. This filing does not detail specific transactions or financial results but serves as a general update.
Why It Matters
This 8-K filing indicates Ocugen is providing updates on its corporate activities and financial reporting to the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for 'Other Events' and financial statements, not indicating any immediate material changes or negative news.
Key Numbers
- 001-36751 — SEC File Number (Identifies Ocugen's filing with the SEC.)
- 19355 — ZIP Code (Part of Ocugen's Malvern, PA business address.)
Key Players & Entities
- Ocugen, Inc. (company) — Registrant
- Histogenics Corp (company) — Former Company Name
- January 29, 2025 (date) — Date of Report
- Malvern, Pennsylvania (location) — Company Headquarters
FAQ
What specific 'Other Events' are being reported by Ocugen, Inc. in this 8-K filing?
The provided text does not specify the 'Other Events'; it only lists 'Other Events' as an item information category.
When was Ocugen, Inc. previously known as Histogenics Corp?
The filing states the date of the name change from Histogenics Corp to Ocugen, Inc. was August 10, 2006.
What is Ocugen, Inc.'s primary business classification according to the SEC filing?
Ocugen, Inc. is classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]'.
What is the business address and phone number for Ocugen, Inc.?
The business address is 11 Great Valley Parkway, Malvern, Pennsylvania 19355, and the phone number is (484) 328-4701.
What is the significance of the 'Conformed Period of Report' date?
The 'Conformed Period of Report' date of January 29, 2025, indicates the period for which the report is being filed and is the earliest event date reported.
Filing Stats: 447 words · 2 min read · ~1 pages · Grade level 10.7 · Accepted 2025-01-29 09:04:19
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value per share OCGN The Nasdaq Sto
Filing Documents
- ocgn-20250129.htm (8-K) — 26KB
- ocugenincpresentation.htm (EX-99.1) — 10KB
- ocugenincpresentation001.jpg (GRAPHIC) — 118KB
- ocugenincpresentation002.jpg (GRAPHIC) — 248KB
- ocugenincpresentation003.jpg (GRAPHIC) — 132KB
- ocugenincpresentation004.jpg (GRAPHIC) — 180KB
- ocugenincpresentation005.jpg (GRAPHIC) — 64KB
- ocugenincpresentation006.jpg (GRAPHIC) — 107KB
- ocugenincpresentation007.jpg (GRAPHIC) — 115KB
- ocugenincpresentation008.jpg (GRAPHIC) — 154KB
- ocugenincpresentation009.jpg (GRAPHIC) — 144KB
- ocugenincpresentation010.jpg (GRAPHIC) — 135KB
- ocugenincpresentation011.jpg (GRAPHIC) — 107KB
- ocugenincpresentation012.jpg (GRAPHIC) — 109KB
- ocugenincpresentation013.jpg (GRAPHIC) — 141KB
- ocugenincpresentation014.jpg (GRAPHIC) — 166KB
- ocugenincpresentation015.jpg (GRAPHIC) — 133KB
- ocugenincpresentation016.jpg (GRAPHIC) — 94KB
- ocugenincpresentation017.jpg (GRAPHIC) — 113KB
- ocugenincpresentation018.jpg (GRAPHIC) — 121KB
- ocugenincpresentation019.jpg (GRAPHIC) — 128KB
- ocugenincpresentation020.jpg (GRAPHIC) — 81KB
- ocugenincpresentation021.jpg (GRAPHIC) — 84KB
- ocugenincpresentation022.jpg (GRAPHIC) — 157KB
- ocugenincpresentation023.jpg (GRAPHIC) — 66KB
- ocugenincpresentation024.jpg (GRAPHIC) — 62KB
- ocugenincpresentation025.jpg (GRAPHIC) — 183KB
- ocugenincpresentation026.jpg (GRAPHIC) — 118KB
- ocugenincpresentation027.jpg (GRAPHIC) — 104KB
- 0001628280-25-002925.txt ( ) — 4794KB
- ocgn-20250129.xsd (EX-101.SCH) — 2KB
- ocgn-20250129_lab.xml (EX-101.LAB) — 21KB
- ocgn-20250129_pre.xml (EX-101.PRE) — 12KB
- ocgn-20250129_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. Attached as Exhibit 99.1 hereto and incorporated herein by reference is a presentation that Ocugen, Inc. will post on its website on January 29, 2025 and may use from time to time in presentations or discussions with investors, analysts, and other parties.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. The following exhibits are being furnished herewith: (d) Exhibits Exhibit No. Document 99.1 Ocugen, Inc. Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 29, 2025 OCUGEN, INC. By: /s/ Shankar Musunuri Name: Shankar Musunuri Title: Chairman, Chief Executive Officer, & Co-Founder 3